QUOTE AND NEWS
Marketwire  May 21  Comment 
HEERLEN, NETHERLANDS -- (Marketwire) -- 05/21/12 -- Royal DSM (EURONEXT AMSTERDAM: DSM), the global Life Sciences and Materials Sciences company, announced today that its indirect wholly-owned subsidiary, Biomedical Acquisition Corporation, has
The Globe and Mail  May 18  Comment 
Royal DSM purchases Ocean Nutrition Canada, plans to expand its dietary supplement division
Benzinga  May 18  Comment 
DSM announced its plans to buy Canadian dietary supplements firm Ocean Nutrition Canada in an all-cash deal for around 420 million euros ($534 million), including debt. (c) 2012 Benzinga.com. Benzinga does not provide investment advice. All...
Marketwire  May 11  Comment 
HEERLEN, THE NETHERLANDS -- (Marketwire) -- 05/11/12 -- Royal DSM today announces that its Annual General Meeting of Shareholders has approved appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. DSM is very pleased
Marketwire  May 11  Comment 
HEERLEN, THE NETHERLANDS -- (Marketwire) -- 05/11/12 -- The DSM Annual General Meeting of Shareholders on 11 May 2012 passed a resolution to declare a dividend for 2011 of EUR1.45 per ordinary share of EUR1.50 par value. An interim dividend of
Marketwire  May 11  Comment 
HEERLEN, THE NETHERLANDS -- (Marketwire) -- 05/11/12 -- Royal DSM today held its Annual General Meeting of Shareholders. The following items were approved: * Adoption of the Financial Statements for 2011 * Adoption of the dividend for 2011 (see also
FiercePharma  May 9  Comment 
A panel of psychiatrists revising the influential Diagnostic and Statistical Manual of Mental Disorders are holding firm to their streamlined diagnosis for autism but are backing off proposals for changes to some others. How the definitions...
The Globe and Mail  May 9  Comment 
IT service provider DSM Computing needs to find further funding for innovation and new product development but doesn't want outside investment
Marketwire  May 8  Comment 
HEERLEN, NETHERLANDS -- (Marketwire) -- 05/08/12 -- -- Q1 EBITDA from continuing operations EUR306 million (Q1 2011: EUR325 million) -- Strong results in Life Sciences due to continued growth in Nutrition -- Materials Sciences showed strong
PR Newswire  May 7  Comment 
BALA CYNWYD, Pa., May 7, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Kensey Nash Corporation. ("Kensey Nash" or the "Company") (Nasdaq: KNSY) relating





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki